Literature DB >> 14506741

Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells.

Kerstin Kleine-Lowinski1, James G Rheinwald, Raina N Fichorova, Deborah J Anderson, John Basile, Karl Münger, Christine M Daly, Frank Rösl, Barrett J Rollins.   

Abstract

Infection of cervical keratinocytes by high-risk HPV is involved in the etiology of cervical carcinoma. Since viral products are immunogenic, development of cancer may require suppression of immune responses directed against infected epithelial cells. Many markers of host immune effector responses decrease as cervical intraepithelial neoplasia progresses. Among these is epithelial cell expression of the chemokine MCP-1, though the mechanism for its suppression is unclear. Here, we show that the E6 and E7 viral oncogenes from high-risk HPV, individually and together, suppress MCP-1 expression in primary epithelial cells derived from the female genital tract. This is not a consequence of global suppression of chemokine expression since other chemokines, including IP-10, IL-8 and RANTES, were less affected. Furthermore, 4 of 6 HPV-positive cervical carcinoma cell lines did not express MCP-1. Our data indicate that suppression of MCP-1 expression is part of the program of high-risk HPV E6/E7-induced transformation of primary epithelial cells. These observations are consistent with a model in which MCP-1 expression by infected keratinocytes, which would stimulate an immune attack on HPV-transformed cells, is suppressed for invasive cervical cancer to appear. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506741     DOI: 10.1002/ijc.11411

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

Review 1.  Early Defensive Mechanisms against Human Papillomavirus Infection.

Authors:  Andrea Moerman-Herzog; Mayumi Nakagawa
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

Review 2.  Evasion of host immune defenses by human papillomavirus.

Authors:  Joseph A Westrich; Cody J Warren; Dohun Pyeon
Journal:  Virus Res       Date:  2016-11-24       Impact factor: 3.303

3.  Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production.

Authors:  Jennifer C Guess; Dennis J McCance
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 4.  Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetrance.

Authors:  Assunta Venuti; Stefan Lohse; Massimo Tommasino; Sigrun Smola
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

5.  Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.

Authors:  Carolina Scagnolari; Fabiana Cannella; Alessandra Pierangeli; Rebecca Mellinger Pilgrim; Guido Antonelli; Dayana Rowley; Margaret Wong; Simon Best; Deyin Xing; Richard B S Roden; Raphael Viscidi
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

6.  Regulation of MCP-1 chemokine transcription by p53.

Authors:  Katrin Hacke; Bladimiro Rincon-Orozco; Gilles Buchwalter; Simone Y Siehler; Bohdan Wasylyk; Lisa Wiesmüller; Frank Rösl
Journal:  Mol Cancer       Date:  2010-04-20       Impact factor: 27.401

7.  High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells.

Authors:  Norifumi Iijima; Edward C Goodwin; Daniel Dimaio; Akiko Iwasaki
Journal:  Virology       Date:  2013-07-18       Impact factor: 3.616

8.  Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer.

Authors:  Hakim Echchannaoui; Matteo Bianchi; David Baud; Martine Bobst; Jean-Christophe Stehle; Denise Nardelli-Haefliger
Journal:  Infect Immun       Date:  2008-03-10       Impact factor: 3.441

9.  Human papillomavirus E7 oncoprotein increases production of the anti-inflammatory interleukin-18 binding protein in keratinocytes.

Authors:  Kathryn H Richards; Rosella Doble; Christopher W Wasson; Mohammed Haider; G Eric Blair; Miriam Wittmann; Andrew Macdonald
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

Review 10.  Macrophages, inflammation, and tumor suppressors: ARF, a new player in the game.

Authors:  Paqui G Través; Alfonso Luque; Sonsoles Hortelano
Journal:  Mediators Inflamm       Date:  2012-12-18       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.